Abstract
IntroductionErtugliflozin, a sodium-glucose cotransporter-2 inhibitor, seems to improve glycemic control in type 2 diabetes mellitus (T2DM). We aim to......
小提示:本篇文献需要登录阅读全文,点击跳转登录